Redhill Biopharma
RDHL
#10161
Rank
A$9.65 M
Marketcap
$7.43
Share price
-2.86%
Change (1 day)
-64.70%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2023 (TTM): A$15.65 Million

According to Redhill Biopharma's latest financial reports the company's current earnings are A$35.74 Million. In 2022 the company made an earning of -A$0.12 Billion, an increase over its 2021 earnings that were of -A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) A$15.65 M-113.99%
2022 -A$0.12 Billion-26.68%
2021 -A$0.16 Billion28.32%
2020 -A$0.12 Billion80.06%
2019 -A$66.06 Million8.97%
2018 -A$60.62 Million-14.76%
2017 -A$71.12 Million55.07%
2016 -A$45.87 Million39.26%
2015 -A$32.94 Million96.9%
2014 -A$16.73 Million0.78%
2013 -A$16.6 Million16.93%
2012 -A$14.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$11.56 B 63,915.21%๐Ÿ‡ซ๐Ÿ‡ท France
A$23.38 B 129,289.91%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.51 B 35,942.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$68.27 M 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-A$0.45 Billion-2,536.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel